BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17556653)

  • 1. Interferon-gamma suppresses cyclooxygenase-2 promoter activity by inhibiting C-Jun and C/EBPbeta binding.
    Deng WG; Montero AJ; Wu KK
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1752-9. PubMed ID: 17556653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential interaction of nuclear factors with the PRE-I enhancer element of the human IL-4 promoter in different T cell subsets.
    Li-Weber M; Salgame P; Hu C; Davydov IV; Krammer PH
    J Immunol; 1997 Feb; 158(3):1194-200. PubMed ID: 9013959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CCAAT/enhancer-binding protein beta in the transcriptional regulation of COX-2 in human amnion.
    Lee YS; Terzidou V; Lindstrom T; Johnson M; Bennett PR
    Mol Hum Reprod; 2005 Dec; 11(12):853-8. PubMed ID: 16399783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of TNF-alpha expression in normal macrophages: the role of C/EBPbeta.
    Pope R; Mungre S; Liu H; Thimmapaya B
    Cytokine; 2000 Aug; 12(8):1171-81. PubMed ID: 10930293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of 3-caffeoyl-4-dicaffeoylquinic acid from Salicornia herbacea against phorbol ester-induced cyclooxygenase-2 expression in macrophages.
    Han EH; Kim JY; Kim HG; Chun HK; Chung YC; Jeong HG
    Chem Biol Interact; 2010 Feb; 183(3):397-404. PubMed ID: 19931518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCAAT/enhancer binding protein beta mediates expression of matrix metalloproteinase 13 in human articular chondrocytes in inflammatory arthritis.
    Hayashida M; Okazaki K; Fukushi J; Sakamoto A; Iwamoto Y
    Arthritis Rheum; 2009 Mar; 60(3):708-16. PubMed ID: 19248099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nitric oxide production by the carbazole compound LCY-2-CHO via blockade of activator protein-1 and CCAAT/enhancer-binding protein activation in microglia.
    Chang LC; Tsao LT; Chang CS; Chen CJ; Huang LJ; Kuo SC; Lin RH; Wang JP
    Biochem Pharmacol; 2008 Aug; 76(4):507-19. PubMed ID: 18586011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating protein 1-mediated cyclooxygenase-2 expression is independent of N-terminal phosphorylation of c-Jun.
    Chen LC; Chen BK; Chang WC
    Mol Pharmacol; 2005 Jun; 67(6):2057-69. PubMed ID: 15772294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydro-N-caffeoyltyramine down-regulates cyclooxygenase-2 expression by inhibiting the activities of C/EBP and AP-1 transcription factors.
    Han EH; Kim JY; Kim HG; Choi JH; Im JH; Woo ER; Jeong HG
    Food Chem Toxicol; 2010 Feb; 48(2):579-86. PubMed ID: 19922759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of oligonol on phorbol ester-induced tumor promotion and COX-2 expression in mouse skin: NF-kappaB and C/EBP as potential targets.
    Kundu JK; Hwang DM; Lee JC; Chang EJ; Shin YK; Fujii H; Sun B; Surh YJ
    Cancer Lett; 2009 Jan; 273(1):86-97. PubMed ID: 18848748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C/EBPbeta regulates TNF induced MnSOD expression and protection against apoptosis.
    Ranjan P; Boss JM
    Apoptosis; 2006 Oct; 11(10):1837-49. PubMed ID: 16850160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helioxanthin inhibits interleukin-1 beta-induced MIP-1 beta production by reduction of c-jun expression and binding of the c-jun/CREB1 complex to the AP-1/CRE site of the MIP-1 beta promoter in Huh7 cells.
    Tseng PC; Hsu HC; Janmanchi D; Lin CH; Kuo YH; Chou CK; Yeh SF
    Biochem Pharmacol; 2008 Oct; 76(9):1121-33. PubMed ID: 18789903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nuclear receptors NUR77 and SF1 play additive roles with c-JUN through distinct elements on the mouse Star promoter.
    Martin LJ; Tremblay JJ
    J Mol Endocrinol; 2009 Feb; 42(2):119-29. PubMed ID: 18987158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of C/EBPbeta mRNA expression and C/EBPbeta promoter activity by protein kinases A and C in a myelomonocytic cell line (HD11).
    Goethe R; Basler T; Phi-van L
    Inflamm Res; 2007 Jul; 56(7):274-81. PubMed ID: 17659432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel tumor necrosis factor alpha-responsive CCAAT/enhancer binding protein site regulates expression of the cartilage-derived retinoic acid-sensitive protein gene in cartilage.
    Imamura T; Imamura C; McAlinden A; Davies SR; Iwamoto Y; Sandell LJ
    Arthritis Rheum; 2008 May; 58(5):1366-76. PubMed ID: 18438857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin immunoprecipitation assay on the rainbow trout opsin proximal promoters illustrates binding of NF-kappaB and c-jun to the SWS1 promoter in the retina.
    Dann SG; Allison WT; Veldhoen K; Johnson T; Hawryshyn CW
    Exp Eye Res; 2004 May; 78(5):1015-24. PubMed ID: 15051482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of a distal enhancer in the transcriptional responsiveness of the human CD200 gene to interferon-gamma and tumor necrosis factor-alpha.
    Chen Z; Marsden PA; Gorczynski RM
    Mol Immunol; 2009 Jun; 46(10):1951-63. PubMed ID: 19386363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
    Cho IJ; Ki SH; Brooks C; Kim SG
    Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidoglycan enhances transcriptional expression of CCAAT/enhancer-binding protein delta gene in mouse macrophages.
    Huang YC; Chang WC; Su JG; Cai JL; Chen CC; Hung JJ; Liu YW
    J Biomed Sci; 2007 May; 14(3):407-18. PubMed ID: 17273900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
    Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.